290 related articles for article (PubMed ID: 29133485)
1. Pyk2 and FAK differentially regulate invadopodia formation and function in breast cancer cells.
Genna A; Lapetina S; Lukic N; Twafra S; Meirson T; Sharma VP; Condeelis JS; Gil-Henn H
J Cell Biol; 2018 Jan; 217(1):375-395. PubMed ID: 29133485
[TBL] [Abstract][Full Text] [Related]
2. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.
Behmoaram E; Bijian K; Jie S; Xu Y; Darnel A; Bismar TA; Alaoui-Jamali MA
Am J Pathol; 2008 Nov; 173(5):1540-50. PubMed ID: 18832579
[TBL] [Abstract][Full Text] [Related]
3. A novel Pyk2-derived peptide inhibits invadopodia-mediated breast cancer metastasis.
Twafra S; Sokolik CG; Sneh T; Srikanth KD; Meirson T; Genna A; Chill JH; Gil-Henn H
Oncogene; 2023 Jan; 42(4):278-292. PubMed ID: 36258022
[TBL] [Abstract][Full Text] [Related]
4. An EGFR-Src-Arg-cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion.
Mader CC; Oser M; Magalhaes MA; Bravo-Cordero JJ; Condeelis J; Koleske AJ; Gil-Henn H
Cancer Res; 2011 Mar; 71(5):1730-41. PubMed ID: 21257711
[TBL] [Abstract][Full Text] [Related]
5. Protein dynamics at invadopodia control invasion-migration transitions in melanoma cells.
Legrand M; Mousson A; Carl P; Rossé L; Justiniano H; Gies JP; Bouvard D; Sick E; Dujardin D; Rondé P
Cell Death Dis; 2023 Mar; 14(3):190. PubMed ID: 36899008
[TBL] [Abstract][Full Text] [Related]
6. Proline-rich tyrosine kinase 2 (Pyk2) regulates IGF-I-induced cell motility and invasion of urothelial carcinoma cells.
Genua M; Xu SQ; Buraschi S; Peiper SC; Gomella LG; Belfiore A; Iozzo RV; Morrione A
PLoS One; 2012; 7(6):e40148. PubMed ID: 22859931
[TBL] [Abstract][Full Text] [Related]
7. PyK2 and FAK connections to p190Rho guanine nucleotide exchange factor regulate RhoA activity, focal adhesion formation, and cell motility.
Lim Y; Lim ST; Tomar A; Gardel M; Bernard-Trifilo JA; Chen XL; Uryu SA; Canete-Soler R; Zhai J; Lin H; Schlaepfer WW; Nalbant P; Bokoch G; Ilic D; Waterman-Storer C; Schlaepfer DD
J Cell Biol; 2008 Jan; 180(1):187-203. PubMed ID: 18195107
[TBL] [Abstract][Full Text] [Related]
8. B cell receptor-induced phosphorylation of Pyk2 and focal adhesion kinase involves integrins and the Rap GTPases and is required for B cell spreading.
Tse KW; Dang-Lawson M; Lee RL; Vong D; Bulic A; Buckbinder L; Gold MR
J Biol Chem; 2009 Aug; 284(34):22865-77. PubMed ID: 19561089
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylated cortactin recruits Vav2 guanine nucleotide exchange factor to activate Rac3 and promote invadopodial function in invasive breast cancer cells.
Rosenberg BJ; Gil-Henn H; Mader CC; Halo T; Yin T; Condeelis J; Machida K; Wu YI; Koleske AJ
Mol Biol Cell; 2017 May; 28(10):1347-1360. PubMed ID: 28356423
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine phosphorylation of cortactin by the FAK-Src complex at focal adhesions regulates cell motility.
Wang W; Liu Y; Liao K
BMC Cell Biol; 2011 Nov; 12():49. PubMed ID: 22078467
[TBL] [Abstract][Full Text] [Related]
11. Involvement of ROS-alpha v beta 3 integrin-FAK/Pyk2 in the inhibitory effect of melatonin on U251 glioma cell migration and invasion under hypoxia.
Xu CS; Wang ZF; Huang XD; Dai LM; Cao CJ; Li ZQ
J Transl Med; 2015 Mar; 13():95. PubMed ID: 25889845
[TBL] [Abstract][Full Text] [Related]
12. Mena
Weidmann MD; Surve CR; Eddy RJ; Chen X; Gertler FB; Sharma VP; Condeelis JS
Sci Rep; 2016 Nov; 6():36142. PubMed ID: 27824079
[TBL] [Abstract][Full Text] [Related]
13. Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells.
Bowden ET; Onikoyi E; Slack R; Myoui A; Yoneda T; Yamada KM; Mueller SC
Exp Cell Res; 2006 May; 312(8):1240-53. PubMed ID: 16442522
[TBL] [Abstract][Full Text] [Related]
14. Cooperation between c-Met and focal adhesion kinase family members in medulloblastoma and implications for therapy.
Guessous F; Yang Y; Johnson E; Marcinkiewicz L; Smith M; Zhang Y; Kofman A; Schiff D; Christensen J; Abounader R
Mol Cancer Ther; 2012 Feb; 11(2):288-97. PubMed ID: 22188814
[TBL] [Abstract][Full Text] [Related]
15. FAK alters invadopodia and focal adhesion composition and dynamics to regulate breast cancer invasion.
Chan KT; Cortesio CL; Huttenlocher A
J Cell Biol; 2009 Apr; 185(2):357-70. PubMed ID: 19364917
[TBL] [Abstract][Full Text] [Related]
16. NH
Nagano M; Hoshino D; Toshima J; Seiki M; Koshikawa N
Cancer Sci; 2020 Dec; 111(12):4393-4404. PubMed ID: 32976654
[TBL] [Abstract][Full Text] [Related]
17. Arg kinase mediates CXCL12/CXCR4-induced invadopodia formation and invasion of glioma cells.
Chen L; Zhu M; Yu S; Hai L; Zhang L; Zhang C; Zhao P; Zhou H; Wang S; Yang X
Exp Cell Res; 2020 Apr; 389(1):111893. PubMed ID: 32035133
[TBL] [Abstract][Full Text] [Related]
18. Ezrin regulates focal adhesion and invadopodia dynamics by altering calpain activity to promote breast cancer cell invasion.
Hoskin V; Szeto A; Ghaffari A; Greer PA; Côté GP; Elliott BE
Mol Biol Cell; 2015 Oct; 26(19):3464-79. PubMed ID: 26246600
[TBL] [Abstract][Full Text] [Related]
19. PYK2 integrates growth factor and cytokine receptors signaling and potentiates breast cancer invasion via a positive feedback loop.
Selitrennik M; Lev S
Oncotarget; 2015 Sep; 6(26):22214-26. PubMed ID: 26084289
[TBL] [Abstract][Full Text] [Related]
20. The significance of proline-rich tyrosine kinase2 (Pyk2) on hepatocellular carcinoma progression and recurrence.
Sun CK; Ng KT; Sun BS; Ho JW; Lee TK; Ng I; Poon RT; Lo CM; Liu CL; Man K; Fan ST
Br J Cancer; 2007 Jul; 97(1):50-7. PubMed ID: 17551499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]